CJ ENM CO., Ltd. (KOSDAQ:035760)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,466,653	1,113,181	1,496,678	2,170,391	2,877,271	2,738,933
Market Cap Growth	-32.17%	-25.62%	-31.04%	-24.57%	5.05%	-12.59%
Enterprise Value	4,033,648	3,768,519	4,896,333	5,083,436	3,859,952	3,558,893
Last Close Price	70700.00	53700.00	72200.00	104700.00	138800.00	137442.77
PE Ratio	-	-	-	-	14.87	48.11
Forward PE	-	-	-	18.92	13.07	16.41
PS Ratio	0.28	0.21	0.34	0.45	0.81	0.81
PB Ratio	0.41	0.30	0.36	0.50	0.69	0.72
P/TBV Ratio	84.46	8.57	3.92	2.77	1.17	1.16
P/FCF Ratio	1.02	0.83	1.25	1.50	4.73	6.01
P/OCF Ratio	0.98	0.79	1.16	1.32	3.68	4.84
PEG Ratio	-	1.85	1.85	1.89	1.31	0.48
EV/Sales Ratio	0.77	0.72	1.12	1.06	1.09	1.05
EV/EBITDA Ratio	2.51	2.21	5.14	3.58	4.74	4.66
EV/EBIT Ratio	108.05	37.10	-	40.21	12.99	13.34
EV/FCF Ratio	2.81	2.81	4.10	3.50	6.34	7.81
Debt / Equity Ratio	0.73	0.78	0.78	0.83	0.52	0.32
Debt / EBITDA Ratio	1.58	1.69	3.42	2.54	2.67	1.56
Debt / FCF Ratio	1.82	2.15	2.73	2.49	3.57	2.62
Asset Turnover	0.54	0.54	0.43	0.53	0.50	0.58
Inventory Turnover	24.90	27.93	26.85	33.44	26.73	21.38
Quick Ratio	0.50	0.61	0.66	0.62	1.03	1.00
Current Ratio	0.63	0.75	0.82	0.73	1.14	1.13
Return on Equity (ROE)	-16.18%	-14.79%	-9.31%	-4.14%	5.70%	1.89%
Return on Assets (ROA)	0.57%	0.66%	-0.14%	0.86%	2.61%	2.85%
Return on Capital (ROIC)	0.79%	0.91%	-0.19%	1.10%	3.27%	3.77%
Return on Capital Employed (ROCE)	1.70%	1.80%	-	2.10%	5.30%	5.60%
Earnings Yield	-37.53%	-45.22%	-21.11%	-5.53%	6.72%	2.08%
FCF Yield	97.82%	120.30%	79.82%	66.87%	21.15%	16.63%
Dividend Yield	-	-	-	-	1.51%	1.16%
Payout Ratio	-	-	-	-	27.93%	48.29%
Buyback Yield / Dilution	-0.01%	-	-	-	-4.53%	-1.01%
Total Shareholder Return	-	-	-	-	-3.02%	0.15%

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.